1665-5044

1665-5044

S1665-50442019000200025

10.24875/rmn.m19000055

México

México

México

México

00 04 2019

00 04 2019

20 2 25 32

1

2016 3rd ed

2

1997 38 Suppl 5 Suppl 5

S2-5

3

2018 75

279-86

4

Levetiracetam Monotherapy Study Group

2007 68

402-8

5

2014 55

1534-43

6

2006 47

1094-120

7

2017 58

512-21

8

2017 58

531-42

9

National Institute for Health and Clinical Excellence 2012

10

2013 54 3 3

551-63

11

2017 12

12

2015 11

13

2016 12

14

2016 12

15

2016 11

16

2017 2

17

2016 4

18

2013 5

19

2018 40

589-98

20

2000 22

75-80

21

2009 50 Suppl 8 Suppl 8

31-6

22

2018 59

905-14

23

2017 145

317-26

24

2010 23

157-63

25

2011 20

369-75

26

2016 22

3212-25

27

2014 83

552-60

28

2014 71

985-93

29

2010 51

7-26

30

1997 26

423-32

31

1999 40

1141-6

32

2017 12

33

2016 6

34

2017 69

59-68

35

2016 9

1533-46

36

2018 55

17-22